Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-09-08ClinicalTrials.gov study NCT01548560
-
CLINICAL_TRIALS study record update · 2017-09-08A Phase 1 Randomized, Double-Blind, Placebo Controlled Clinical Trial to Evaluate the Safety, Mucosal Immunogenicity and Innate Immune Responses of Recombinant Adenovirus Serotype 26 HIV-1 Vaccine (Ad26.ENVA.01) in Healthy, HIV-1 Uninfected Adults (Ad26.ENVA.01 (rAd26) HIV-1 Mucosal/IPCAVD-003 Vaccine Study)
-
CLINICAL_TRIALS study record update · 2017-09-08A Double-Blind, Randomised, Placebo-Controlled Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess Delivery of Dapivirine From the Matrix Vaginal Ring Containing 25 MG of Dapivirine
-
CLINICAL_TRIALS study record update · 2017-08-31A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2017-08-28Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies: A Randomized, Placebo-controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-08-18PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation
-
CLINICAL_TRIALS study record update · 2017-08-15Phase 3 Study of the Efficacy and Safety of the Microbicide Carraguard® in Preventing HIV Seroconversion in Women
-
CLINICAL_TRIALS study record update · 2017-08-15A Randomized, Controlled, Double-Blind, Cross-Over Trial of Safety, Effect on Genital Tract HIV Shedding, and Acceptability of Vaginal Use of Carraguard by HIV-Infected Women
-
CLINICAL_TRIALS study record update · 2017-08-14A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide
-
CLINICAL_TRIALS study record update · 2017-08-14A Phase 1 Safety and Acceptability Study of Carraguard® Among HIV Positive Women and Men in Durban, South Africa
-
CLINICAL_TRIALS study record update · 2017-08-14A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety and Acceptability of Carraguard™ (PC-515) Vaginal Gel Among Heterosexual Couples in Chiang Rai
-
CLINICAL_TRIALS study record update · 2017-08-14A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing STI/HIV Transmission
-
CLINICAL_TRIALS study record update · 2017-07-31Effects of Thymidine Sparing Regimens on Mitochondrial Metabolism and Adipocyte Apoptosis
-
CLINICAL_TRIALS study record update · 2017-07-31A Phase I Study to Evaluate the Safety, Tolerability, and Effect of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), on Markers of HIV Persistence in ART-treated, HIV-infected Adults
-
CLINICAL_TRIALS study record update · 2017-07-21Maximizing Opportunity: HIV Prevention in Hospitalized Russian Drinkers
-
CLINICAL_TRIALS study record update · 2017-07-17A Randomized Trial of Enhanced Nursing Telephone Support to Improve Medication Self-Management and Viral Outcomes of Antiretroviral Therapy-Experienced Patients
-
CLINICAL_TRIALS study record update · 2017-07-14A Brief, Clinic-Based, HIV Prevention Program for African American Teen Males
-
CLINICAL_TRIALS study record update · 2017-07-13Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daiy Valacyclovir in the Reduction of HSV-2 Recurrences and Viral Shedding
-
CLINICAL_TRIALS study record update · 2017-07-11Impact of Antiretroviral Therapy on Biomarkers of Inflammation Associated With Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2017-07-02VRC 011: A Phase I Clinical Trial of Intramuscular, Subcutaneous and Intradermal Administration of an HIV-1 Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, and an HIV-1 Multiclade Adenoviral Vector Vaccine,VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers
-
CLINICAL_TRIALS study record update · 2017-07-02Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2017-07-02A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP, in Uninfected Adult Volunteers
-
CLINICAL_TRIALS study record update · 2017-07-02A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Were Previously Immunized With VRC-HIVDNA009-00-VP in VRC 004
-
CLINICAL_TRIALS study record update · 2017-07-02VRC 008: A Phase I Clinical Trial of a Prime-Boost HIV-1 Vaccination Schedule: Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by Multiclade Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers
-
CLINICAL_TRIALS study record update · 2017-07-02An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals